Deliveries of Pfizer-BioNTech vaccine could start before Christmas
Drug firm Pfizer has announced that ist Covid vaccine candidate was 95% successful in the final stage trials. Similarly, the BioNtech vaccine was also 95% effective against the infection. The US Food and Drug Administration is likely to approve the emergency use of these vaccines by mid-December. If this happens, the delivery of these vaccines may start before Christmas. BioNTech will apply for emergency approval on Friday.